MLchartDataset catalogue

carrimycin

Term · Oncology and biomedicine · MLC-T-ONC-012319

A 16-membered macrolide antibiotic, with potential antibacterial and immunomodulatory activities. Upon administration, carrimycin targets and binds to bacterial ribosomes, thereby inhibiting protein synthesis. Carrimycin may be active against some Gram-positive bacteria and Mycobacterium tuberculosis. It may also have immunomodulatory activity, presumably through a different mechanism, which has not yet been characterized.

Table 1. Record
IdentifierMLC-T-ONC-012319
FieldOncology and biomedicine
Synonymsshengjimycin; biotechspiramycin
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012319",
  "term": "carrimycin",
  "field": "Oncology and biomedicine",
  "definition": "A 16-membered macrolide antibiotic, with potential antibacterial and immunomodulatory activities. Upon administration, carrimycin targets and binds to bacterial ribosomes, thereby inhibiting protein synthesis. Carrimycin may be active against some Gram-positive bacteria and Mycobacterium tuberculosis. It may also have immunomodulatory activity, presumably through a different mechanism, which has not yet been characterized.",
  "synonyms": [
    "shengjimycin",
    "biotechspiramycin"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/carrimycin/"
}

Record 4,284 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.